Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Will Inhibitex Be The Next Big Acquisition in the HCV Space ? (INHX, $10.69)

Gilead (GILD) is certainly paying up for Pharmasset with its offer to buy the company at $137 per share ($11…
Read more…